Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature

SAN FRANCISCO and SUZHOU, China, Dec. 18, 2025 /PRNewswire/ — Innovent Biologics,…

Milesight Announces Mobile Surveillance Unit Solution Powered by Outdoor-Ready Cameras

XIAMEN, China, Dec. 18, 2025 /PRNewswire/ — Milesight today announced its Mobile…

SK hynix First to Complete Intel Data Center Certification for 32Gb Die-based 256GB Server DDR5 RDIMM

–          SK hynix 32Gb 1b die-based 256GB server DDR5 RDIMM completes compatibility…

Kia PV5 Earns Global Recognition Across Performance, Safety, Design and Innovation in 2025

SEOUL, South Korea, Dec. 18, 2025 /PRNewswire/ — The Kia PV5, the…

Historic production of graphene enhanced cement successfully completed

Highlights Production of 600 tonnes of low-carbon PureGRAPH® enhanced cement successfully completed by…

EDMI and PLUS ES set to transform energy infrastructure across Australia

BRISBANE, Australia, Dec. 18, 2025 /PRNewswire/ — EDMI, a global leader in intelligent…

Nabsys and Hitachi Present Electronic Genome Mapping Data at Japanese Society of Human Genetics (JSHG) 2025 Annual Meeting

TOKYO, Dec. 18, 2025 /PRNewswire/ — Nabsys 2.0, LLC (Nabsys), a pioneer…

REALTY ONE GROUP REAFFIRMS ITS PURPOSE AMID INDUSTRY CONSOLIDATION: LEADING WITH HEART, COOLTURE AND THE POWER OF ONE

LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ — As the real estate…